TransMedics Group, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TMDX research report →
Companywww.transmedics.com
TransMedics Group, Inc. , a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
- CEO
- Waleed H. Hassanein
- IPO
- 2019
- Employees
- 728
- HQ
- Andover, MA, US
Price Chart
Valuation
- Market Cap
- $2.35B
- P/E
- 13.60
- P/S
- 3.70
- P/B
- 4.73
- EV/EBITDA
- 19.71
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 59.09%
- Op Margin
- 14.85%
- Net Margin
- 27.04%
- ROE
- 41.92%
- ROIC
- 6.94%
Growth & Income
- Revenue
- $605.49M · 37.13%
- Net Income
- $190.29M · 436.58%
- EPS
- $5.60 · 423.36%
- Op Income
- $108.58M
- FCF YoY
- 265.04%
Performance & Tape
- 52W High
- $156.00
- 52W Low
- $60.10
- 50D MA
- $101.18
- 200D MA
- $120.31
- Beta
- 2.06
- Avg Volume
- 1.28M
Get TickerSpark's AI analysis on TMDX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 9, 26 | Forsyth Matthew S. | other | 0 |
| Mar 4, 26 | Lovell Stephanie | sell | 1,193 |
| Mar 4, 26 | Weill David | other | 3,571 |
| Mar 4, 26 | Weill David | sell | 3,571 |
| Mar 4, 26 | Weill David | other | 3,571 |
| Mar 4, 26 | Hernandez Gerardo | other | 5,912 |
| Mar 4, 26 | Hernandez Gerardo | other | 1,324 |
| Mar 4, 26 | Hernandez Gerardo | sell | 5,912 |
| Mar 2, 26 | Hernandez Gerardo | sell | 375 |
| Mar 4, 26 | Hernandez Gerardo | other | 5,912 |
Our TMDX Coverage
We haven't published any research on TMDX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TMDX Report →